Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.4474
+0.0172 (4.00%)
At close: May 13, 2025, 4:00 PM
0.4352
-0.0122 (-2.73%)
Pre-market: May 14, 2025, 6:52 AM EDT
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $3.38M in the quarter ending March 31, 2025, a decrease of -10.14%. This brings the company's revenue in the last twelve months to $17.54M, down -2.06% year-over-year. In the year 2024, Ekso Bionics Holdings had annual revenue of $17.93M, down -1.94%.
Revenue (ttm)
$17.54M
Revenue Growth
-2.06%
P/S Ratio
0.56
Revenue / Employee
$265,818
Employees
66
Market Cap
12.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EKSO News
- 8 days ago - Ekso Bionics Holdings, Inc. (EKSO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Ekso Bionics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 15 days ago - Ekso Bionics to Report First Quarter 2025 Financial Results on May 5 – Conference Call to Follow - GlobeNewsWire
- 20 days ago - Bionic P&O Chosen as First Distributor of Ekso Indego® Personal Within the Orthotics & Prosthetics Industry - GlobeNewsWire
- 2 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow - GlobeNewsWire
- 3 months ago - NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry - GlobeNewsWire